OxyContin Maker Settles Opioid Crisis Lawsuit With Oklahoma For $270 Million

FILE - This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. Oklahoma's attorney general will announce a settlement Tuesday, March 26, 2019, with Purdue Pharma, one of 13 drug manufacturers named in a state lawsuit that accuses them of fueling the opioid epidemic, but the other companies still face what's expected to be the first of numerous state lawsuits to go to trial. (AP Photo/Toby Talbot, File)
FILE - This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. Oklahoma's attorney general will announce a settlement Tuesday, March 26, 2019, with Purdue Pharma, on... FILE - This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. Oklahoma's attorney general will announce a settlement Tuesday, March 26, 2019, with Purdue Pharma, one of the drug manufacturers named in a state lawsuit that accuses them of fueling the opioid epidemic. (AP Photo/Toby Talbot, File) MORE LESS
Start your day with TPM.
Sign up for the Morning Memo newsletter

OKLAHOMA CITY (AP) — The maker of OxyContin and the company’s controlling family agreed to pay $270 million in a deal announced Tuesday with the state of Oklahoma to settle allegations they helped set off the nation’s deadly opioid crisis with their aggressive marketing of the powerful painkiller.

It is the first settlement to come out of the recent coast-to-coast wave of lawsuits against Stamford, Connecticut-based Purdue Pharma that threaten to push the company into bankruptcy and have stained the name of the Sackler family, whose members are among the world’s foremost philanthropists.

“The addiction crisis facing our state and nation is a clear and present danger, but we’re doing something about it today,” Oklahoma Attorney General Mike Hunter said.

Nearly $200 million will go toward establishing the National Center for Addiction Studies and Treatment at Oklahoma State University in Tulsa, while local governments will get $12.5 million. The Sackler family is responsible for $75 million of the settlement.

The deal comes two months before Oklahoma’s lawsuit against Purdue Pharma and other drug companies was set to become the first one in the barrage of litigation to go to trial.

Plaintiffs’ attorney Paul Hanly, who is not involved in the Oklahoma case but is representing scores of other governments, welcomed the deal, saying: “That suggests that Purdue is serious about trying to deal with the problem. Hopefully, this is the first of many.”

But some activists were furious, saying they were denied the chance to hold Purdue Pharma fully accountable in public, in front of a jury.

“This decision is a kick in the gut to our community,” said Ryan Hampton, who is recovering from opioid addiction. “We deserve to have our day in court with Purdue. The parents, the families, the survivors deserve at least that. And Oklahoma stripped that from us today.”

He added: “We cannot allow Purdue to cut backroom deals with state attorneys general.”

An attorney for Purdue Pharma did not immediately return a call seeking comment.

Opioids, including heroin and prescription drugs like OxyContin, were a factor in a record 48,000 deaths across the U.S. in 2017, according to the Centers for Disease Control and Prevention. Oklahoma recorded about 400 opioid deaths that year. State officials have said that since 2009, more Oklahomans have died from opioids than in vehicle crashes.

Purdue Pharma introduced OxyContin in the 1990s and marketed it aggressively to doctors, making tens of billions of dollars from the drug. But has been hit with close to 2,000 lawsuits from state and local governments trying to hold the company responsible for the scourge of addiction.

The lawsuits accuse the company of downplaying the addiction risks and pushing doctors to increase dosages even as the dangers became known. According to a court filing, Richard Sackler, then senior vice president responsible for sales, proudly told the audience at a launch party for OxyContin in 1996 that it would create a “blizzard of prescriptions that will bury the competition.”

Purdue Pharma has settled other lawsuits over the years, and three executives pleaded guilty to criminal charges in 2007. But this is the first settlement to come out of the surge of litigation that focuses largely on the company’s more recent conduct.

The agreement was announced after the Oklahoma Supreme Court on Monday denied a request from drugmakers to postpone the start of the state’s trial in late May. The remaining defendants in Oklahoma’s 2017 lawsuit still face trial.

Lance Lang, a 36-year-old recovering user from Oklahoma City, said he is glad some of the settlement will go toward helping those still suffering from addiction.

“My heart breaks for those that we’ve already lost. I’ve buried several myself,” said Lang, who now helps recovering users find housing. “But I also know we have waiting lists of dozens and dozens for our facilities, and the state has waiting lists of hundreds and hundreds of people who need help right now.”

But Cheryl Juaire, whose 23-year-old son Corey died of an overdose in 2011, said she was devastated to hear about the settlement. She had been organizing a group of hundreds of mothers to go to the first day of the trial and stand outside with photos of their dead children.

Jauire, who lives in Marlborough, Massachusetts, said a complete airing of the facts is the only way to fully hold Purdue to account.

“They can’t settle,” she said. “That would be a huge disservice to the tens of thousands of families here in the United States who buried a child. That’s blood money from our children.”

As the accusations have mounted, the Sacklers have faced personal lawsuits and growing public pressure. A Massachusetts court filing made public earlier this year found that family members were paid at least $4 billion from 2007 until last year.

The Sacklers are major donors to cultural institutions, and the family name is emblazoned on the walls at many of the world’s great museums and universities. But in the past few weeks, the Tate museums in London and the Guggenheim Museum in New York have cut ties with the family, and other institutions have come under pressure to turn down donations or remove the Sackler name.

This month, Purdue Pharma officials acknowledged that are considering filing for bankruptcy because of the crush of lawsuits.

More than 1,400 federal lawsuits against pharmaceutical companies have been consolidated in front of a single judge in Cleveland who is pushing the drugmakers and distributors to reach a nationwide settlement with state and local governments.

Latest News

Notable Replies

  1. It it just me, or does it sound like they got off dirt cheap?

  2. Forbes had the Sackler family fortune around $13 Billion back in 2016…

    Until we start seeing settlements with a “B” at the start, this is basically couch change for those fuckers.

    Let alone that I want to see this coming out of their fucking pockets, not just the corporations they hide behind.

    Bunch of sick, twisted murderers.

  3. A Massachusetts court filing made public earlier this year found that Sackler family members were paid at least $4 billion from 2007 “until last year.”

    And that only includes what they received from Rush Limbaugh’s housekeeper.

  4. "And Oklahoma stripped that from us today.”

    HAHAHAHAHA! Welcome to the ReWhited States of Amurikkka. May I take your rights?

    And guess what, champ: that $270M will probably get used by the GOP assholes running your idiot state to cut taxes for the wealthy.

Continue the discussion at forums.talkingpointsmemo.com

16 more replies

Participants

Avatar for system1 Avatar for paulw Avatar for kwoodgr Avatar for mondfledermaus Avatar for old_curmudgeon Avatar for dave48 Avatar for irasdad Avatar for sniffit Avatar for 26degreesrising Avatar for ottnott Avatar for khaaannn Avatar for katwillow Avatar for pshah Avatar for rickjones Avatar for castor_troy Avatar for causeforconcern Avatar for rascal_crone

Continue Discussion
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Associate Editor:
Editor at Large:
General Counsel:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher:
Front End Developer:
Senior Designer: